SODIUM PHOSPHATES
Generic: SODIUM PHOSPHATES
GLENMARK PHARMACEUTICALS INC.Manufacturer
INTRAVENOUSRoute
SODIUM PHOSPHATEActive Substance
2026-02-23Original Approval
SODIUM PHOSPHATES is FDA application ANDA220683, sponsored by CAPLIN. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
ASTHENIA
19 reports
2
DIARRHOEA
19 reports
3
RENAL FAILURE ACUTE
19 reports
4
NAUSEA
17 reports
5
CONSTIPATION
16 reports
6
DEHYDRATION
14 reports
7
FALL
14 reports
8
DIZZINESS
13 reports
9
PYREXIA
13 reports
10
URINARY TRACT INFECTION
13 reports